Digitalis Ventures is a brand that engineers innovative solutions to address unmet needs in the field of health. With a team of experts who possess deep technical and domain knowledge, our capabilities span across venture investing, technology development, and public-interest problem-solving. This unique combination allows us to creatively build and scale enduring results.

DV Investments, a division of Digitalis Ventures, offers venture capital to early-stage companies in life sciences, health technology, and services, as well as animal health. Our goal is to provide support to our portfolio companies throughout their development. DV Proving Grounds focuses on designing, developing, and delivering entrepreneurial solutions to unmet health needs through data science, technology development, and new ventures.

In addition, Digitalis Commons, our affiliated non-profit organization, builds scalable solutions that have a significant impact on important health problems. With our multidisciplinary team and extensive network, we are able to forge deep and effective relationships with entrepreneurs, technical experts, research institutions, and financial partners. This collaborative approach enables us to create enduring solutions at scale.

Our brand name, Digitalis, is inspired by the Digitalis plant, which has been used since the 1700s for the treatment of heart disease. It represents our commitment to the development of nature-derived compounds and the importance of measurement science in therapeutic advancement. The legacy of our founding partner, Dr.

Thomas W. Smith, a renowned clinician and researcher, continues to inspire and guide our work in the field of health